Location, location, location: mapping the lymphoma tumor microenvironment using spatial transcriptomics

• Published in: Frontiers in oncology Vol. 13; p. 1258245
• Main Authors: Pickard, Keir, Stephenson, Emily, Mitchell, Alex, Jardine, Laura, Bacon, Chris M
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 04.10.2023
• Subjects: lymphoma; Oncology; personalized medicine; single cell RNA sequencing; spatial transcriptomics; tumor microenvironment; tumor microenvironment; single cell RNA sequencing; spatial transcriptomics; lymphoma; personalized medicine
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2023.1258245

Lymphomas are a heterogenous group of lymphoid neoplasms with a wide variety of clinical presentations. Response to treatment and prognosis differs both between and within lymphoma subtypes. Improved molecular and genetic profiling has increased our understanding of the factors which drive these clinical dynamics. Immune and non-immune cells within the lymphoma tumor microenvironment (TME) can both play a key role in antitumor immune responses and conversely also support lymphoma growth and survival. A deeper understanding of the lymphoma TME would identify key lymphoma and immune cell interactions which could be disrupted for therapeutic benefit. Single cell RNA sequencing studies have provided a more comprehensive description of the TME, however these studies are limited in that they lack spatial context. Spatial transcriptomics provides a comprehensive analysis of gene expression within tissue and is an attractive technique in lymphoma to both disentangle the complex interactions between lymphoma and TME cells and improve understanding of how lymphoma cells evade the host immune response. This article summarizes current spatial transcriptomic technologies and their use in lymphoma research to date. The resulting data has already enriched our knowledge of the mechanisms and clinical impact of an immunosuppressive TME in lymphoma and the accrual of further studies will provide a fundamental step in the march towards personalized medicine.